Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart

Diabetes

Volumn 48, Issue 5, 1999, Pages 1101-1107

  Virkamäki, Antti ^a   Yki Järvinen, Hannele ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE DERIVATIVE; GLYCOGEN; GLYCOGEN SYNTHASE; HEXOKINASE; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; GLYCOGEN SYNTHESIS; HEART MUSCLE; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUS ABDOMINIS MUSCLE;

ALLOSTERIC REGULATION; ANIMALS; BLOOD GLUCOSE; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUCOSAMINE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE-6-PHOSPHATE; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOLYSIS; HEART; HEXOKINASE; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; MYOCARDIUM; RATS; RATS, WISTAR;

EID: 0040112971     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.5.1101     Document Type: Article

References (36)

1. Yki-Järvinen H: Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies. Diabet Med 14:S32-S37, 1997
2. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712, 1991
3. Virkamäki A, Daniels MC, Hämäläinen S, Utriainen T, McClain D, Yki-Järvinen H: Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 138:2501-2507, 1997
4. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N: In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96:132-140, 1995
5. Crook ED, McClain DA: Regulation of glycogen synthase and protein phosphatase-1 by hexosamines. Diabetes 45:322-327, 1996
6. Robinson KA, Sens DA, Buse MG: Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles: study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor. Diabetes 42:1333-1346, 1993
7. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H: Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes 41:571-580, 1992
8. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
9. Nyomba BL, Freymond D, Raz I, Stone K, Mott DM, Bogardus C: Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. Metabolism 39:1204-1210, 1990
10. Giaccari A, Morviducci L, Zoreetta D, Sbraccia P, Leonetti F, Caiola S, Buongiorno A, Bonadonna RC, Tamburrano G: In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat possible relevance to the maladaptive responses to chronic hyperglycemia. Diabetologia 38:518-524, 1995
11. Marshall S, Garvey WT, Traxinger RR: New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J 5:3031-3036, 1991
12. Kornfeld R: Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J Biol Chem 242:3135-3141, 1967
13. Crook ED, Zhou J, Daniels M, Neidigh JL, McClain DA: Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase. Diabetes 44:314-320, 1995
14. Wang P, Bantle G, Sørensen NB: Effect of metabolites and phosphorylase on the D to I conversion of glycogen synthase from human polymorphonuclear leukocytes. Biochim Biophys Acta 496:436-447, 1977
15. Crane RK, Sols A: The non-competitive inhibition of brain hexokinase by glucose-6-phospnate and related compounds. J Biol Chem 210:597-606, 1954
16. Virkamäki A, Yki-Järvinen HL: Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134:2072-2078, 1994
17. Maley GF, Maley F: Regulatory properties and subunit structure of chick embryo deoxycytidylate deaminase. J Biol Chem 243:4506-4512, 1968
18. Maley GF, Maley F: Active and inactive states of deoxycytidylate deaminase and their relation to subunit structure. J Biol Chem 243:4513-4516, 1968
19. Comb DG, Roseman S: Glucosamine metabolism. IV. Glucosamine-6-phosphate deaminase. J Biol Chem 232:807-827, 1958
20. 14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes 46:1106-1110, 1997
21. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
22. Kornfeld S, Ginsburg V: The metabolism of glucosamine by tissue culture cells. Exp Cell Res 41:592-600, 1966
23. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, McClain DA.: Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 97:1235-1241, 1996
24. Passonneau JV, Lowry OH: Enzymatic Analysis: A Practical Guide. Totowa, NJ, Humana Press, 1993
25. Hebert LF Jr, Daniels MC, Zhou J, Crook ED, Turner RK, Simmons ST, Neidigh JL, Zhu JS, Baron AD, McClain DA: Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936, 1996
26. Bogardus C, Lillioja S, Stone K, Mott D: Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73:1185-1190, 1984
27. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED: High glucose-induced transforming growth factor beta 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169, 1998
28. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE: Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A 89:8150-8154, 1992
29. Khac LD, Eboue-Bonis D, Chambaut AM, Clauser H: The use of glucosamine as a metabolic probe in the rat diaphragm. The effect of insulin on its metabolic fate. Eur J Biochem 31:86-94, 1972
30. Patti ME, Virkamäki A, Landaker EJ, Yki-Järvinen H: Activation of the hexosamine pathway by glucosamine in vivo decreases insulin-stimulated PI 3-kinase in skeletal muscle (Abstract). Diabetes 47 (Suppl. 1):A8, 1998
31. Keppler DO, Rudigier JF, Bischoff E, Decker KF: The trapping of uridine phosphates by D-galactosamine: D-glucosamine, and 2-deoxy-D-galactose. A study on the mechanism of galactosamine hepatitis. Eur J Biochem 17:246-253, 1970
32. Kirkman BR, Whelan WJ: Glucosamine is a normal component of liver glycogen. Growth Regul 194:6-11, 1986
33. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT: Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle: implications for glucose toxicity. J Clin Invest 96:2792-2801, 1995
34. Miles PD, Higo K, Romeo OM, Lee MK, Rafaat K, Olefsky JM: Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance. Diabetes 47:395-400, 1998
35. Bonadonna RC, Monauni T, Zenti MG, Targher G, Caruso B, Caputo M, Bonora E, Muggeo M: Mechanisms of "glucose toxicity" in man. Studies with glucosamine (Abstract). Diabetologia 39 (Suppl. 1):A14, 1996
36. Hresko RC, Heimberg H, Chi MMY, Mueckler M: Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273:20658-20668, 1998